This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2000 May 20;355(9217):1738-9.

doi: 10.1016/s0140-6736(00)02255-8.

Calcium antagonists and secondary prevention of myocardial infarction; [comment]

Affiliations

PMID: 10832818
DOI: 10.1016/s0140-6736(00)02255-8

Comment

Calcium antagonists and secondary prevention of myocardial infarction; [comment]

C Rosendorff. Lancet. 2000.

. 2000 May 20;355(9217):1738-9.

doi: 10.1016/s0140-6736(00)02255-8.

Author

Affiliation

¹ Department of Medicine, Mount Sinai School of Medicine, New York, NY 10029, USA.

PMID: 10832818
DOI: 10.1016/s0140-6736(00)02255-8

No abstract available

PubMed Disclaimer

Comment on

Diltiazem in acute myocardial infarction treated with thrombolytic agents: a randomised placebo-controlled trial. Incomplete Infarction Trial of European Research Collaborators Evaluating Prognosis post-Thrombolysis (INTERCEPT).
Boden WE, van Gilst WH, Scheldewaert RG, Starkey IR, Carlier MF, Julian DG, Whitehead A, Bertrand ME, Col JJ, Pedersen OL, Lie KI, Santoni JP, Fox KM. Boden WE, et al. Lancet. 2000 May 20;355(9217):1751-6. doi: 10.1016/s0140-6736(00)02262-5. Lancet. 2000. PMID: 10832825 Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information